XMAB

Welcome to the Brand page for “XMAB”, which is offered here for Pharmaceuticals, monoclonal antibodies and fragments thereof for therapeutic use for the treatment of cancer and proliferative cell diseases;pharmaceutical and biological product development consultation relating to monoclonal antibodies; and pharmaceutical and biological product development for others relating to monoclonal antibodies;.

Its status is currently believed to be active. Its class is unavailable. “XMAB” is believed to be currently owned by “XENCOR, INC.”